Year None202420232022202120202019201820172016 Date Latest Press Release October 17, 2016 Eiger Announces Orphan Designation of Exendin 9-39 for Treatment of Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS) from European Medicines Agency (EMA) October 13, 2016 Eiger Announces Abstracts and Presentations of LOWR HDV Program at the American Association for the Study of Liver Diseases (AASLD) Meeting September 7, 2016 Eiger Announces Completion of Dosing in Phase 2 LOWR HDV - 4 Study at Hannover Medical School September 6, 2016 Eiger BioPharmaceuticals to Present at the BioCentury NewsMakers in the Biotech Industry Conference on September 9th September 1, 2016 Eiger BioPharmaceuticals to Present at the 5th Annual Liolios Gateway Conference on September 7, 2016 August 18, 2016 Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock August 17, 2016 Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock August 10, 2016 Eiger BioPharmaceuticals Reports Second Quarter 2016 Financial Results August 8, 2016 Eiger BioPharmaceuticals to Present at the 2016 Wedbush PacGrow Healthcare Conference on August 17th July 25, 2016 Eiger BioPharmaceuticals Announces First Patient Dosed in Phase 2 ULTRA Study of Ubenimex in Secondary Lymphedema Pagination First page « first Previous page ‹ previous … Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Current page 23 Page 24 Page 25 Next page next › Last page last »